Form 4: Inspire Medical Systems Director Shawn McCormick Sells Shares Under 10b5-1 Plan

Director Shawn McCormick sold 800 shares of Inspire Medical Systems (INSP) common stock at $220 per share on September 9, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Shawn McCormick, a director of Inspire Medical Systems, Inc. (INSP), sold 800 shares of common stock on September 9, 2024.
• The sale was executed at a price of $220 per share.
• Following the transaction, McCormick directly owns 23,140 shares of common stock.
• McCormick also indirectly owns 3,000 shares through a trust.
• The transaction was conducted under a Rule 10b5-1 trading plan established on May 24, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it reports a routine transaction under a pre-existing trading plan. There is no indication of positive or negative implications for the company.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential alignment between management's actions and company performance. The use of a 10b5-1 plan suggests the sale was pre-planned and not based on recent non-public information.

Stakeholder Impact

• The sale of shares by a director could be perceived negatively by some shareholders, but the existence of a 10b5-1 plan mitigates concerns about insider information being used for personal gain.

Key Dates